FWD1802
FWD1802-001C
Phase 2 small_molecule active
Quick answer
FWD1802 for Metastatic Breast Cancer is a Phase 2 program (small_molecule) at Forward Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Forward Pharmaceuticals Co.,
- Indication
- Metastatic Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active